Presentation + Paper
14 March 2023 Ex vivo mesoscopic assessment of drug delivery and target engagement via lifetime FRET
Shan Gao, Amit Verma, Margarida Barroso, Xavier Intes
Author Affiliations +
Abstract
Time-domain mesoscopic fluorescence molecular tomography (TD-MFMT) provides a unique window for non-invasively monitoring drug delivery efficacy parameters in targeted anticancer research, such as drug-receptor engagement and intra-tumoral heterogeneity. We investigate the potential of TD-MFMT for ex vivo assessment of Trastuzumab-HER2 target engagement and drug distribution in two types of breast and ovarian cancer tumor xenograft models (AU565 and SK-OV-3) via lifetime FRET technique. FRET fraction level and fluorescence drug distribution results reveal that drug accumulation within tumors cannot be automatically associated with targeted cellular drug delivery.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Shan Gao, Amit Verma, Margarida Barroso, and Xavier Intes "Ex vivo mesoscopic assessment of drug delivery and target engagement via lifetime FRET", Proc. SPIE 12357, Visualizing and Quantifying Drug Distribution in Tissue VII, 123570F (14 March 2023); https://doi.org/10.1117/12.2650632
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Fluorescence resonance energy transfer

Tumors

Fluorescence

Target acquisition

Fluorescence tomography

In vivo imaging

Molecules

RELATED CONTENT


Back to Top